Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma

Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma

Bo Yang,1– 3,* Lin-Lin Ji,1,2,* Hong-Liang Xu,1,* Xiao-Ping Li,3 Hong-Gang Zhou,4 Ting Xiao,4 Xiao-He Li,4 Zhou-Yong Gao,1,2 Jian-Zhong Li,5 Wei-Dong Zhang,3 Guang-Shun Wang,1 Ming-Jiang Li3 1Department of Thoracic Surgery, Tianjin Baodi Hospital, Baodi Clinical College of Tianjin Medical...

Full description

Bibliographic Details
Main Authors: Yang B, Ji LL, Xu HL, Li XP, Zhou HG, Xiao T, Li XH, Gao ZY, Li JZ, Zhang WD, Wang GS, Li MJ
Format: Article
Language:English
Published: Dove Medical Press 2021-06-01
Series:Journal of Inflammation Research
Subjects:
zc3h12d
lung adenocarcinoma
hypomethylation
tumor microenvironment
prognosis
Online Access:https://www.dovepress.com/zc3h12d-a-novel-of-hypomethylated-and-immune-related-for-prognostic-ma-peer-reviewed-fulltext-article-JIR

Internet

https://www.dovepress.com/zc3h12d-a-novel-of-hypomethylated-and-immune-related-for-prognostic-ma-peer-reviewed-fulltext-article-JIR

Similar Items